Huntington Ingalls (HII) Misses on Q1 Earnings, Tops Sales
The largest military shipbuilder in the U.S., Huntington Ingalls Industries, Inc. HII is the prime industrial employer in Virginia. Huntington Ingalls, originally an affiliate of Northrop Grumman Corp., was spun off in Mar 2011. It operates major shipyards in Louisiana, Mississippi and Virginia.
Huntington Ingalls primarily deals with the supply of nuclear and non-nuclear ships to the U.S. Navy and Coast Guards. The company also provides manufacturing, engineering and management services to the commercial and non-commercial oil, gas and energy markets.
Estimate Trend & Surprise History
Coming to the earnings surprise, Huntington Ingalls has surpassed the Zacks Consensus Estimate in three of the last four quarters with an average positive surprise of 3.85%. Investors should also note the Zacks Consensus Estimate for the first quarter of 2018 remained same in the last 7 days.
Zacks Rank
Currently, the company has a Zacks Rank #3 (Hold), but that could definitely change following the company’s earnings report which was just released. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
We have highlighted some of the key stats from this just-revealed announcement below:
Earnings Miss: Huntington Ingalls missed on first-quarter earnings. Our consensus called for EPS of $4.07, and the company reported EPS of $3.48.
Revenue Beat: The company posted revenues of $1.87 billion, which surpassed the Zacks consensus estimate of $1.76 billion.
Huntington Ingalls Industries, Inc. Price and EPS Surprise
Huntington Ingalls Industries, Inc. Price and EPS Surprise | Huntington Ingalls Industries, Inc. Quote
Key Developments to Note
New business contracts for first quarter were approximately $2.6 billion for Huntington Ingalls. Total backlog amounted to $22 billion as of Mar 31, 2018.
Stock Price: In the pre-market trading session, Huntington Ingalls’ first-quarter results made no significant impact on its share price. Yet, it would be interesting to see how the market reacts to the earnings release during the trading session today.
Check back later for our full write up on this HII earnings report later!
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Huntington Ingalls Industries, Inc. (HII) : Free Stock Analysis Report
To read this article on Zacks.com click here.
